关于 Cytori Therapeutics, Inc.
Cerenome, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system (CNS) cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Cerenome also commercialized a molecular diagnostic service, CNSide®.
Source: Wikipedia
总部3020 Callan Road, 92121, San Diego, US
成立2016
状态营业中
专利205 项专利
IMPROVEMENT OF ENDOTHELIAL CELL FUNCTIONWO2019168685A1 · 2019
REGENERATIVE CELL THERAPY FOR MUSCULOSKELETAL DISORDERSEP3522984A1 · 2019
法律信息
| 法定名称 | Cytori Therapeutics, Inc. |
|---|---|
| LEI | 549300XD2PHUC73HMY31在 GLEIF 上查看 ↗ |
| 注册地址 | 3020 Callan Road, 92121, San Diego, US |
| 状态 | 营业中 |
来源: GLEIF · 更新于 Oct. 16, 2026